Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial - Archive ouverte HAL Access content directly
Journal Articles Lancet Oncology Year : 2014

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

, , , (1) , , , , , , , , , , , , , ,
1
J. Taieb
  • Function : Author
J. Tabernero
  • Function : Author
E. Mini
  • Function : Author
Fabien Subtil
G. Folprecht
  • Function : Author
Jl. van Laethem
  • Function : Author
J. Thaler
  • Function : Author
J. Bridgewater
  • Function : Author
Ln. Peterson
  • Function : Author
H. Blons
  • Function : Author
L. Collette
  • Function : Author
E. van Cutsem
  • Function : Author
P. Rougier
  • Function : Author
R. Salazar
  • Function : Author
L. Bedenne
  • Function : Author
Jf. Emile
  • Function : Author
P. Laurent-Puig
  • Function : Author
C. Lepage
  • Function : Author
Not file

Dates and versions

hal-02045524 , version 1 (22-02-2019)

Identifiers

  • HAL Id : hal-02045524 , version 1

Cite

J. Taieb, J. Tabernero, E. Mini, Fabien Subtil, G. Folprecht, et al.. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial. Lancet Oncology, 2014, 15, pp.862-873. ⟨hal-02045524⟩
20 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More